Zydus Lifesciences gets 2 USFDA observations for Ahmedabad transdermal manufacturing site

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-07-20 06:00 GMT   |   Update On 2024-07-20 06:40 GMT
Advertisement

Ahmedabad: Zydus Lifesciences has received 2 observations from the US Food and Drug Administration (USFDA) at the closure of the inspection at the group's transdermal manufacturing site located at SEZ in Ahmedabad.

The inspection was conducted from July 15 to 19, 2024.

"The Company is confident of addressing the issues raised by the USFDA within the stipulated timeline, and is committed to resolving the same at the earliest," the Company stated.

Advertisement

Read also: USFDA nod to Zydus Lifesciences diabetes drug

Medical Dialogues team had earlier reported that had received four observations from the U.S. Food and Drug Administration (USFDA) at the closure of the inspection at the SEZ Onco Injectable manufacturing plant at Ahmedabad

Read also: USFDA inspection: Zydus Lifesciences gets 4 observations for Ahmedabad plant

Headquartered in Ahmedabad, Zydus Lifesciences Limited is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer-related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News